HomeCompareCKNHF vs JNJ

CKNHF vs JNJ: Dividend Comparison 2026

CKNHF yields 2.45% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CKNHF wins by $31.9K in total portfolio value
10 years
CKNHF
CKNHF
● Live price
2.45%
Share price
$60.02
Annual div
$1.47
5Y div CAGR
37.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62.2K
Annual income
$14,463.28
Full CKNHF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CKNHF vs JNJ

📍 CKNHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCKNHFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CKNHF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CKNHF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CKNHF
Annual income on $10K today (after 15% tax)
$208.15/yr
After 10yr DRIP, annual income (after tax)
$12,293.79/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, CKNHF beats the other by $8,307.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CKNHF + JNJ for your $10,000?

CKNHF: 50%JNJ: 50%
100% JNJ50/50100% CKNHF
Portfolio after 10yr
$46.2K
Annual income
$9,576.34/yr
Blended yield
20.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CKNHF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
4.8
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CKNHF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCKNHFJNJ
Forward yield2.45%2.13%
Annual dividend / share$1.47$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR37.6%28%
Portfolio after 10y$62.2K$30.3K
Annual income after 10y$14,463.28$4,689.40
Total dividends collected$37.6K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CKNHF vs JNJ ($10,000, DRIP)

YearCKNHF PortfolioCKNHF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,037$336.95$10,592$272.30+$445.00CKNHF
2$12,288$478.25$11,289$357.73+$999.00CKNHF
3$13,833$684.72$12,123$472.89+$1.7KCKNHF
4$15,792$991.24$13,141$629.86+$2.7KCKNHF
5$18,353$1,455.29$14,408$846.81+$3.9KCKNHF
6$21,813$2,174.94$16,021$1,151.60+$5.8KCKNHF
7$26,664$3,324.17$18,122$1,588.22+$8.5KCKNHF
8$33,756$5,225.53$20,930$2,228.20+$12.8KCKNHF
9$44,626$8,507.30$24,792$3,191.91+$19.8KCKNHF
10$62,213$14,463.28$30,274$4,689.40+$31.9KCKNHF

CKNHF vs JNJ: Complete Analysis 2026

CKNHFStock

Clarkson PLC provides integrated shipping services worldwide. The company operates through four segments: Broking, Financial, Support, and Research. The Broking segment offers services to ship owners and charterers in the transportation of various cargoes by sea; and to buyers and sellers/yards related to sale and purchase transactions, as well as futures broking operation. This segment deals in containers, deep sea tankers, dry cargo, liquefied petroleum gas and ammonia, liquefied natural gas, offshore, petrochemical gases, renewables, shortsea, specialized products, sale and purchase, and PCTC markets; and towage, salvage, and transportation markets. The Financial segment provides investment banking services for maritime, oil services, and natural resources sectors; structured asset finance services and projects in the shipping, offshore, and real estate sectors; and freight derivative products. This segment also offers equity and fixed income sales and trading; equity and credit research; and corporate access and corporate finance services, including advising clients on various equity and debt capital markets, and M&A transactions. The Support segment provides port and agency, freight forwarding, supplies, and tools for the marine and offshore industries. The Research segment offers shipping-related information and publications; and collects, validates, analyses, and manages data to inform various business decisions. This segment provides web products, such as Shipping Intelligence Network and World Fleet Register to printed publications, including Shipping Intelligence Weekly and Offshore Intelligence Monthly; data and analysis services for IPO and bond issues; customer service contracts, primarily to the financial, government, insurance, equipment, and shipbuilding sectors; and valuations to owners and the financial community. It also offers research and legal services. The company was founded in 1852 and is headquartered in London, the United Kingdom.

Full CKNHF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CKNHF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CKNHF vs SCHDCKNHF vs JEPICKNHF vs OCKNHF vs KOCKNHF vs MAINCKNHF vs ABBVCKNHF vs MRKCKNHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.